Addressing the changing health landscape
Baker Heart and Diabetes Institute is an independent, internationally renowned medical research facility, with a history spanning more than 92 years. The Institute's work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes, cardiovascular disease and associated metabolic diseases.
The comprehensive range of research undertaken to target these deadly diseases, combined with the flexibility and innovation to respond to changing health and community needs, is unique and sets the Baker Institute apart from other health and research Institutes.
The Institute's mission is to reduce death and disability from cardiovascular disease, diabetes and related disorders; two prevalent and complex diseases responsible for the most deaths and the highest health costs in the world.
With Australia facing an ageing population and rapidly growing rates of chronic disease, our work has never been more important to Australian communities, as well as the global communities in which it operates.
The Institute is well positioned to address these challenges. The Institute's highly diverse team includes cardiologists, diabetes physicians, bench-top scientists, epidemiologists, dietitians, biostaticians, computational biologists, nurse educators, remote healthcare workers and physical activity experts. Together, they are working to translate laboratory findings into new approaches to prevention, treatment and care.
These new approaches include actively embracing technological advances in areas such as genomics and informatics, which are enhancing our ability to more precisely diagnose disease and target prevention and treatment. The breadth of our work, combined with our multi-omic focus, means we are ideally placed to harness these developments to more precisely target metabolic disease.